Cotización Arch Biopartners - ARCH

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

1.72

Postura de Compra

1.72

Postura de Venta

1.73

Volume Operado de la Acción

8,600

1.67 Rango del Día 1.77

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

107.669M

Precio Anterior

1.70

Precio de Apertura

1.77

Hora

100

1.72

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

Acciones en circulación

62,598,000

Rendimiento del Dividendo

Ratio Precio/Utilidad

-32.02

Beneficio por acción (BPA)

-0.05

turnover

1.98M

Beneficio neto

-3.33M

Sector

Coml Physical, Biologcl Resh

Industria

Advertising Agencies

Sitio web

archbiopartners.com

Sede

Toronto, Ontario, Can

Fundado

2010

Arch Biopartners Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker ARCH. The last closing price for Arch Biopartners was $1.70. Over the last year, Arch Biopartners shares have traded in a share price range of $ 0.00 to $ 0.00.

Arch Biopartners currently has 62,598,000 shares in issue. The market capitalisation of Arch Biopartners is $106.42 million. Arch Biopartners has a price to earnings ratio (PE ratio) of -32.02.

Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Closes Units for Debt Settlement

TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has closed a transaction that...

Units for Debt Settlement

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to...

Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Alberta Health Services (AHS) has approved...

Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins

Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its...

Arch Biopartners Closes Non-Brokered Private Placement

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the...

Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary’s Conjoint Health...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ARCH - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Arch Biopartners?

El precio actual de las acciones de Arch Biopartners es $ 1.72

¿Cuántas acciones de Arch Biopartners están en circulación?

Arch Biopartners tiene 62,598,000 acciones en circulación

¿Cuál es la capitalización de mercado de Arch Biopartners?

La capitalización de mercado de Arch Biopartners es CAD 106.42M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Arch Biopartners?

Arch Biopartners ha negociado en un rango de $ 0.00 a $ 0.00 durante el último año

¿Cuál es el ratio PE (precio/beneficio) de Arch Biopartners?

El ratio precio/beneficio de Arch Biopartners es -32.02

¿Cuál es el ratio de efectivo a ventas de Arch Biopartners?

El ratio de efectivo a ventas de Arch Biopartners es 53.63

¿Cuál es la moneda de reporte de Arch Biopartners?

Arch Biopartners presenta sus resultados financieros en CAD

¿Cuál es el último ingresos anual de Arch Biopartners?

El último ingresos anual de Arch Biopartners es CAD 1.98M

¿Cuál es el último beneficio anual de Arch Biopartners?

El último beneficio anual de Arch Biopartners es CAD -3.33M

¿Cuál es la dirección registrada de Arch Biopartners?

La dirección registrada de Arch Biopartners es 27 ST. CLAIR AVENUE EAST, P.O. BOX 305, TORONTO, ONTARIO, M5V 1M1

¿Cuál es la dirección del sitio web de Arch Biopartners?

La dirección del sitio web de Arch Biopartners es archbiopartners.com

¿En qué sector industrial opera Arch Biopartners?

Arch Biopartners opera en el sector ADVERTISING AGENCIES

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MPTH.HMapath Capital Corp	$ 0.035 (250.00%)	2k
GAR.HGreen Arrow Resources Inc	$ 0.025 (150.00%)	24k
MAHMarksmen Energy Inc	$ 0.01 (100.00%)	1,000
ALTAlturas Minerals Corp	$ 0.01 (100.00%)	1.1k
CMILCapella Minerals Ltd	$ 0.01 (100.00%)	22k
OEG.HONEnergy Inc	$ 0.01 (-88.24%)	5.2k
OVL.HOlivier Ventures Inc	$ 0.005 (-66.67%)	1,000
MEED.PMeed Growth Corp	$ 0.035 (-65.00%)	25k
GNFIGenifi Inc	$ 0.005 (-50.00%)	12k
NICKNickelex Resource Corporation	$ 0.005 (-50.00%)	270.3k
QNCQuantum Emotion Corp	$ 0.345 (-21.59%)	6.06M
TAUCommon Stock	$ 0.58 (0.00%)	5.91M
GPUSAlset AI Ventures Inc	$ 0.095 (-13.64%)	3.95M
MATEBlockmate Ventures Inc	$ 0.20 (-11.11%)	3.85M
CPERCoppercorp Resources Inc	$ 0.13 (-43.48%)	3.23M